+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Synthetic Biology Market - Growth, Trends, and Forecast (2019 - 2024)

  • ID: 4763920
  • Report
  • March 2019
  • Region: Global
  • 115 pages
  • Mordor Intelligence
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Amyris Inc.
  • Genscript
  • Intrexon Corporation
  • Koninklijke DSM N.V.
  • New England Biolabs Inc.
  • Novozymes A/S
  • MORE
Market Overview

The synthetic biology market has witnessed a CAGR of nearly 20%. There are certain factors propelling the growth of the market, including increasing support from the government and private institutions, increasing R&D investments in drug discovery, and the development and declining cost of DNA sequencing and synthesizing.

The increasing involvement of government bodies, research institutes, and large-scale organizations in synthetic biology research activities is likely to support the market over the next few years. The governments of various nations have been providing support for research on synthetic biology, due to its wide applications. There has been a lot of research studies and projects, running in various countries with respect to synthetic biology that have tried to tap various complexities in the genomes of organisms, and hence, have helped in creating more effective and efficient therapies to treat them.

There has also been an increasing application of genome editing in agriculture. Hence, with the increasing support from the government and private institutions, the market is expected to increase during the forecast period.

The synthetic biology technologies and products are also finding significant usage in various application areas. Since the organisms engineered with synthetic biology techniques are relatively reasonable, owing to their use in various industrial applications, which also translates in a reduction in the cost of research, the demand for these techniques is increasing considerably across the world.

Scope of the Report

As per the scope of the report, synthetic biology is a new interdisciplinary area that involves the application of engineering principles to biology. It aims at the re-designing and fabrication of biological components and systems. Therefore, it combines the knowledge of genomics and chemical synthesis of DNA for the rapid production of catalogued DNA sequences. It is a novel technology and the value chain of a product manufacturing includes steps that require collaborative efforts by two or more companies.

Key Market Trends

North America is Expected to Dominate the Synthetic Biology Market in the Forecast Period

North America is estimated to account for the largest share in the synthetic biology market due to factors, such as the increasing demand for bio-based products, increased investments in synthetic biology companies, and rising R&D funding for synthetic biology. The increasing support from the government and private institutions and increasing R&D investments in drug discovery and development are also major growth factors expected to drive the market during the forecast period.

Competitive Landscape

The competitive analysis of the companies reveals that most of the companies are concentrating on agreements followed by product launches for the expansion of their business. The value chain of the product manufacturing includes the steps that require collaborative efforts by two or more companies and this is the key reason for agreements among the companies.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Amyris Inc.
  • Genscript
  • Intrexon Corporation
  • Koninklijke DSM N.V.
  • New England Biolabs Inc.
  • Novozymes A/S
  • MORE
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Support from Government and Private Institutions
4.2.2 Increasing R&D Investments in Drug Discovery and Development
4.2.3 Declining Cost of DNA Sequencing and Synthesizing
4.3 Market Restraints
4.3.1 Bio-safety and Bio-security
4.3.2 Ethical Issues
4.3.3 Reimbursement Cuts Causing Pricing Pressure
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Core Products
5.1.2 Enabling Products
5.1.3 Enabled Products
5.2 By Applications
5.2.1 Healthcare
5.2.2 Chemicals (Including Bio-Fuels)
5.2.3 Agriculture
5.2.4 Others (Biosecurity, R&D, Energy, and Environment)
5.3 Geography
5.3.1 North America
5.3.1.1 US
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 UK
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Amyris Inc.
6.1.2 E. I. Du Pont De Nemours and Company
6.1.3 Genscript
6.1.4 Integrated DNA Technologies Inc.
6.1.5 Intrexon Corporation
6.1.6 New England Biolabs Inc.
6.1.7 Novozymes A/S
6.1.8 Koninklijke DSM N.V.
6.1.9 Synthetic Genomics Inc.
6.1.10 Thermo Fisher Scientific Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Amyris Inc.
  • E. I. Du Pont De Nemours and Company
  • Genscript
  • Integrated DNA Technologies Inc.
  • Intrexon Corporation
  • New England Biolabs Inc.
  • Novozymes A/S
  • Koninklijke DSM N.V.
  • Synthetic Genomics Inc.
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown
Adroll
adroll